Mari Nakazawa

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Radical Prostatectomy

Tyrosine Kinase

Prostate Cancer

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Mari Nakazawa, Mike Fang, Tyrus Vong, Jane Zorzi, Paige Griffith, Robert A Anders, Kiyoko Oshima, Amy K Kim, Jacqueline Laurin, Kelly J Lafaro, Christopher R Shubert, William R Burns, Jin He, Richard Andrew Burkhart, Benjamin Philosophe, Jeffrey Meyer, Robert P Liddell, Christos S Georgiades, Kelvin Hong, Won Jin Ho, Nilofer S Azad, Alexandra T Strauss, Mark Yarchoan
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC. Cancer research communications 4 (8) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Mari Nakazawa, Mike Fang, Tyrus Vong, Jane Zorzi, Paige Griffith, Robert A Anders, Kiyoko Oshima, Amy K Kim, Jacqueline Laurin, Kelly J Lafaro, Christopher R Shubert, William R Burns, Jin He, Richard Andrew Burkhart, Benjamin Philosophe, Jeffrey Meyer, Robert P Liddell, Christos S Georgiades, Kelvin Hong, Won Jin Ho, Nilofer S Azad, Alexandra T Strauss, Mark Yarchoan
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC. Cancer research communications 4 (8) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Mari Nakazawa, Mike Fang, Tyrus Vong, Jane Zorzi, Paige Griffith, Robert A Anders, Kiyoko Oshima, Amy K Kim, Jacqueline Laurin, Kelly J Lafaro, Christopher R Shubert, William R Burns, Jin He, Richard Andrew Burkhart, Benjamin Philosophe, Jeffrey Meyer, Robert P Liddell, Christos S Georgiades, Kelvin Hong, Won Jin Ho, Nilofer S Azad, Alexandra T Strauss, Mark Yarchoan
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC. Cancer research communications 4 (8) (2024)
Mari Nakazawa, Mike Fang, Catherine Handy Marshall, Tamara L Lotan, Pedro Isaacsson Velho, Emmanuel S Antonarakis
Clinical and genomic features of SPOP-mutant prostate cancer. The Prostate (2021)